Status:
COMPLETED
Clinical Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens
Lead Sponsor:
Alcon Research
Conditions:
Myopia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the clinical performance of an investigational contact lens over 30 days of daily wear.
Detailed Description
Subjects will wear two products and be expected to attend 4 office visits. The individual duration of participation will be approximately 60 days (30 days for each product).
Eligibility Criteria
Inclusion
- Key
- Able to understand and sign an approved Informed Consent form;
- Willing and able to attend all scheduled study visits as required by the protocol;
- Current wearer of spherical weekly/monthly soft contact lenses in both eyes with at least 3 months wearing time of 5 days per week and 10 hours per day;
- Other protocol-defined inclusion criteria may apply.
- Key
Exclusion
- Current or prior Biofinity contact lens wearer in the past 3 months;
- Monovision contact lens wearer;
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
August 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 18 2020
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04476784
Start Date
August 17 2020
End Date
November 18 2020
Last Update
October 26 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Alcon Investigative Site
Maitland, Florida, United States, 32751
2
Alcon Investigative Site
Bloomington, Illinois, United States, 61704
3
Alcon Investigative Site
Pittsburg, Kansas, United States, 66762
4
Alcon Investigative Site
Shawnee Mission, Kansas, United States, 66204